Related Experiment Videos
Thyroid nodules in Graves' disease: classification, characterization, and response to treatment
1Department of Medicine, University of Maryland School of Medicine, Baltimore, USA.
Thyroid : Official Journal of the American Thyroid Association
|September 16, 1998
Summary
Thyroid nodules are common in Graves' disease patients, but most are benign. Careful evaluation is crucial as 10% of nodules may be cancerous, especially solitary cold nodules.
Area of Science:
- Endocrinology
- Oncology
- Pathology
Background:
- Thyroid nodules are frequently observed in patients with Graves' disease.
- Distinguishing nodules from coexistent thyroid malignancy is critical for appropriate patient management.
- Alternative etiologies for nodules in Graves' disease are more common than cancer.
Purpose of the Study:
- To characterize thyroid nodule types in Graves' disease patients.
- To evaluate nodule response to various treatments.
- To stratify the risk of thyroid malignancy in these patients.
Main Methods:
- Retrospective single-center study of 468 Graves' disease patients (ages 12-75).
- Patients were treated with radioiodine, near-total thyroidectomy, antithyroid drugs, or observation.
- Nodules were classified, and malignancy risk was assessed based on pathology and treatment response.
Main Results:
- 12.8% of patients had nodules, classified into four groups including solitary hypofunctional nodules and multiple nodules.
- Thyroid cancer was diagnosed in 1.3% of all patients (10% of those with nodules).
- Most nodules represented benign autoimmune changes or nodular goiter; malignancy risk was higher in solitary cold nodules.
Conclusions:
- Thyroid nodules are common in Graves' disease, mostly benign manifestations of autoimmune disease or goiter.
- Fine-needle aspiration biopsy (FNAB) is key; benign cytology supports nonsurgical therapy.
- Solitary cold nodules require close monitoring due to a significant risk of malignancy.